Join the pharmacometrics experts at Cognigen as they discuss how the experiences of this past year and the lessons learned from our industry’s response to meet the urgent demands for COVID-19 treatments and vaccines has prompted a reexamination of the culture of R&D. In particular, we will discuss and explore the critical attributes (and attitudes) that we need to exhibit in our work to go beyond working quickly.

The goal of the webinar is to start a new conversation, with participation from the audience, about how scientists at all levels of Pharma R&D can work more thoughtfully while increasing their impact on the delivery of innovation.